Express Pharma

DECEMBER 7, 2023

India Pharma Inc, hailed for its prowess in the production of high-quality generic medicines, now needs to shift from a conventional, volume-based business strategy to a value-based approach to keep it up its growth momentum. In this context, finding the right opportunities and understanding the challenges has become crucial.

Generic Medicine 105

Generic Medicine Documentation 105

RX Note

MARCH 24, 2024

As early as 1968, the first edition of Drug Index for Malaysia & Singapore (DIMS) was published. Core Features Apart from being a source of product leaflet , MIMS also provides some very useful resources. The app was released on both the Google Play Store and Apple App Store for public download. External Links MIMS Malaysia MIMS CPD

Generic Medicine 40

Generic Medicine 40

Express Pharma

APRIL 11, 2023

The pundits are unanimous in their response – changes in the US generic drug market. The US is the biggest market for generic medicines (~90 per cent of prescriptions are fulfilled by generic drugs). Ensure full kit: Preparatory work for a new project (material, information, etc.)

Drug Development 98

Drug Development Generic Medicine Documentation 98

Pharmaceutical Technology

MAY 3, 2023

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

PharmaState Academy

JANUARY 29, 2024

Mr. Shailesh Kapadia spearheaded the discussion on international pharmaceutical marketing, underlining the importance of clear information regarding career prospects in this field. With over 18 years of experience, Mr. Kapadia shared insights into various international business models and strategies for marketing generic and branded drugs.

Generic Medicine 52

Generic Medicine Packaging 52

pharmaphorum

OCTOBER 11, 2022

Nonetheless, still, he said, the industry is doing little to access the necessary information for a post-treatment patient-first approach. Talking through their generic medicines, of which the company has more than 1,000 projects ongoing, Schultz noted that more than half of the leading medicines on the WHO’s list of medicines are Teva’s.

Generic Medicine 98

Generic Medicine Compounding 98

Quality Matters

JANUARY 23, 2023

The aim is to provide evidence to inform public investment and policy reforms that build medicines supply chain resilience and reduce the potential for disruptions. Powered by more than 250 million data points spanning 92% of generic medicines approved in the U.S.,

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Biosimilars Communication 52

Pharmaceutical Technology

DECEMBER 19, 2022

Joy Polefrone, the executive director of the organization, says it aims to build a cluster of partners who are capable of manufacturing generic medicines. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9 million as part of the Build Back Better Regional Challenge.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

Quality Matters

MAY 22, 2023

Identification of upstream medicines supply chain risks can enable regulatory and industry action to reduce potential disruptions and shortages by informing risk mitigation strategies, public and private investment, as well as policy reforms that build more resilience, Bray and other panelists suggested.

Generic Medicine 52

Generic Medicine Chemotherapy 52

Pharma in Brief

JUNE 21, 2020

These amendments are intended to lower the prices of patented medicines in Canada. Medicines that do not fall into one of the three groups of existing patented medicines will be regulated as new patented medicines and assigned to either Category I or Category II. The consultation: next steps.

Biosimilars 40

Biosimilars Generic Medicine Dosage Documentation 40

Quality Matters

OCTOBER 24, 2023

Analysis leveraging USP’s Medicine Supply Map suggests many of the essential cancer medicines have inherently vulnerable supply chains and are at greater risk for shortage compared to other generic medicines. The closer the risk score is to 100%, the greater the risk for that drug to be in shortage in the next 12 months.

Hospitals 52

Hospitals Generic Medicine Chemotherapy 52

Quality Matters

APRIL 18, 2024

While reflecting the positive impacts of USP focus areas, in many cases these efforts also will facilitate data collection, target setting, and information sharing that can help USP stakeholders meet their own ESG goals. These USP documentary standards are recognized in U.S.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Packaging Generic Medicine 59

Quality Matters

SEPTEMBER 15, 2023

For example, while some stakeholders may perceive PCM to be primarily for innovators and not for makers of generic medicines or biotech companies, it “can be for generic companies, biotechnology companies, and so on, and we have had engagements with generic drug companies in our emerging technologies program already,” Fisher said. “I

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Communication 52

Quality Matters

JUNE 26, 2023

Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. FDA categories as complex products and/or of guidelines for development and approval of their generic versions.

Dosage 52

Dosage Generic Medicine Labelling 52

Express Pharma

FEBRUARY 14, 2024

Explaining the situation, Dr Farhat Mantoo, Executive Director, MSF South Asia informed that MSF has appealed to the Indian government through a letter to the Prime Minister to continue rightfully rejecting the inclusion of intellectual property provisions in the EFTA negotiations that are harmful for access to affordable medicines from India.

Generic Medicine 103

Generic Medicine Vaccines 103

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102

Express Pharma

JUNE 12, 2024

Pharma services have witnessed extensive innovation from contract development and manufacturing organisation (CDMO), contract research organisation, pharma information technology (Pharma IT). The ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana’ (9) promotes retail outlets to provide quality generic medicines at affordable prices.

Generic Medicine 105

Generic Medicine Vaccines Diabetes Immunity 105

pharmacy mentor

AUGUST 22, 2024

The deductions work as follows: Branded Medicines (Part VIIIA Category C) : 5% discount Generic Medicines (Part VIIIA Categories A and M) : 20% discount Appliances (Part IX) : 9.85% discount Understanding these deductions is critical, especially when many medicines are unavailable at or below the Drug Tariff price.

Community Pharmacies 52

Community Pharmacies Generic Medicine Drug Pricing Documentation 52

Express Pharma

JUNE 21, 2024

Pharma services have witnessed extensive innovation from contract development and manufacturing organisation (CDMO), contract research organisation, pharma information technology (Pharma IT). The ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana’ (9) promotes retail outlets to provide quality generic medicines at affordable prices.

Generic Medicine 102

Generic Medicine Vaccines Diabetes Immunity 102

European Pharmaceutical Review

DECEMBER 19, 2022

A generic medicine, Diethyl fumarate Accord (dimethyl fumarate), received a positive opinion for the treatment of multiple sclerosis (MS), a chronic disease affecting the central nervous system. This rare genetic disorder causes muscle weakness and is often fatal.

Generic Medicine 104

Generic Medicine Vaccines Chemotherapy 104

Quality Matters

MAY 30, 2024

This urgency drove USP and the American Cancer Society Cancer Action Network (ACS CAN) to combine our expertise and insights to develop a set of principles, informed by feedback from a range of healthcare stakeholders, to support a comprehensive and coordinated response to U.S. drug shortages.

Generic Medicine 49

Generic Medicine Hospitals Vaccines 49

Quality Matters

MAY 18, 2023

Innovative business models Beyond innovation in manufacturing, innovative business models also can provide potential solutions to medicines supply chain vulnerabilities, as evidenced by Civica. The non-profit maker of essential generic medicines was established by a group of U.S. Coukell observed.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 21, 2022

Biosimilar medicine Ximluci (ranibizumab) for the treatment of neovascular age-related macular degeneration, a progressive retinal macular disease, causing gradual vision impairment, mainly in the elderly population. 11 medicines for indication extension.

Vaccines 98

Vaccines Generic Medicine Biosimilars 98

Express Pharma

SEPTEMBER 11, 2023

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Rating BX: Awarded to generic products presumed to be therapeutically non-equivalent.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

Quality Matters

MARCH 31, 2025

This collaboration also helps inform how USP tackles real-world quality challenges and advocates for strengthening patient access to quality medicine. Convention Sectors convene Members around areas key to USPs work such as biologics, innovation, and generic medicines to collaborate on these focused topics.

Generic Medicine 72

Generic Medicine 72

European Pharmaceutical Review

FEBRUARY 3, 2025

Additionally, the CHMP recommended the generic medicine Eltrombopag Accord (eltrombopag) to treat primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C. The drug was indicated as a treatment for certain patients with mild cognitive impairment or dementia due to Alzheimers disease.

Vaccines 52

Vaccines Generic Medicine Chemotherapy Biosimilars 52